Belgian Court Clears Genzyme to Acquire Pharming Unit | GenomeWeb

NEW YORK, Oct. 30 – Genzyme was given the green light from a court in Belgium to acquire rival Pharming NV, currently in receivership, Genzyme said on Tuesday.

Pharming Group, the subsidiary’s parent company, said it plans to appeal the ruling. In September, the company said it opposed an offer from Genzyme because the bid was too low.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.